#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic lymphocytic leukaemia refractory Thymic carcinoma Bone marrow disorder Epidermolysis bullosa Cytomegalovirus infection Acute myeloid leukaemia refractory Cutaneous T-cell lymphoma recurrent Paraneoplastic neurological syndrome Haematological malignancy Kawasaki's disease Autoimmune disorder Autoimmune haemolytic anaemia Autoimmune hepatitis Gastrointestinal neuroendocrine tumour Hypochondroplasia More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma recurrent – Treatment Marfan’s syndrome – Trials in Disease Cystic fibrosis Leukoencephalopathy Inclusion body myositis – Diagnostics Breast angiosarcoma – Treatment Crigler-Najjar syndrome Osteosarcoma recurrent Haemophagocytic lymphohistiocytosis – Diagnostics Marginal zone lymphoma refractory – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vibozilimod Abc-35B-116 Entinostat Cilgavimab Lisinopril Abrocitinib Sisunatovir Pantothenate Sodium Tivozanib Dronedarone Pevonedistat Ixazomib Agrostis Stolonifera Pollen Setrusumab Indometacin Ph. Eur. Norfloxacin Gefitinib SELTOREXANT Elamipretide Trihydrochloride Timrepigene Emparvovec More therapies…

    Learn about Your Condition

    Obstructive pancreatitis Medullary thyroid cancer Gastrointestinal melanoma Eosinophilic gastritis Aortic aneurysm Sinusitis bacterial Juvenile absence epilepsy Haemorrhage intracranial Guttate psoriasis Bronchostenosis Bone metabolism disorder Ischaemic skin ulcer Coronary artery bypass Mitral valve incompetence Epiphysiolysis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier De Versailles

Centre Hospitalier De Versailles

177 Rue De Versailles, Le Chesnay, Le Chesnay-Rocquencourt, 78150, France

Want to learn more about this study or check if you can participate? Contact us.

  • A Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety

    Recruiting

    3 1
    Investigated Diseases:
    • Metabolic dysfunction-associated steatohepatitis
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Austria Belgium Bulgaria Czechia France Germany +6

  • A Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis

    Recruiting

    3 1
    Investigated Diseases:
    • Metabolic dysfunction-associated steatohepatitis
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Austria Belgium Bulgaria Czechia France Germany +6

  • A Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma

    Recruiting

    2 1
    Investigated Drugs:
    • LY3537031
    France Germany The Netherlands Poland

  • Efficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial

    Recruiting

    4 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • LUNSEKIMIG
    Belgium Denmark Estonia Finland France Germany +7

  • Efficacy and safety of GB-0895 as adjunctive therapy in adults and adolescents with severe uncontrolled asthma (randomized, placebo‑controlled)

    Recruiting

    3 1
    Investigated Diseases:
    • Asthma
    Belgium Estonia France Ireland Italy Slovakia +1

  • Study of Blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Asparaginase
    • Blinatumomab
    • Crisantaspase
    Austria Belgium Bulgaria Czechia Denmark Estonia +11

  • Study of Ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Azacitidine
    • Cytarabine
    • Daunorubicin Hydrochloride
    Belgium Czechia France Germany Greece Hungary +4

  • A study testing prednisone combined with antibiotics compared to antibiotics alone in adults with septic arthritis to improve joint health

    Recruiting

    3 1 1
    Investigated Diseases:
    • Arthritis infective
    Investigated Drugs:
    • Prednisone
    France

  • A study comparing brelovitug to bulevirtide for treating chronic hepatitis delta infection in patients currently receiving bulevirtide

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Hepatitis D
    Investigated Drugs:
    • Bjt-778
    • Bulevirtide
    Austria Czechia France Germany Italy Romania +1

  • Study of Revumenib and Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia with NPM1 Gene Mutation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cytarabine
    • Daunorubicin Hydrochloride
    • Idarubicin Hydrochloride
    Austria Belgium Czechia France Germany Greece +7
1 2 3 … 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!